Item 2.02. Results of Operations and Financial Condition.
On November 5, 2009, Idera Pharmaceuticals, Inc. announced its financial
results for the quarter ended September 30, 2009. The full text of the press
release issued in connection with the announcement is attached as Exhibit 99.1
to this Current Report on Form 8-K and is incorporated herein by reference.
The information under Item 2.02 in this Form 8-K (including Exhibit 99.1) is
being furnished and shall not be deemed "filed" for purposes of Section 18 of
the Securities Exchange Act of 1934 (the "Exchange Act"), or otherwise subject
to the liabilities of that section, nor shall it be deemed incorporated by
reference in any filing under the Securities Act of 1933 or the Exchange Act,
except as expressly set forth by specific reference in such a filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
The following exhibit relating to Item 2.02 shall be deemed to be furnished, and
not filed:
99.1 Press release issued by Idera Pharmaceuticals, Inc. on November 5, 2009
